Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value ($000): $173,855 (100.0% shares, 0.0% debt)

Holdings (30)

VNDA VANDA PHARMACEUTICALS INC 13.3%

Value ($000) $23,189 Shares 1,260,288 Est. Cost $21.40 Unrealized +6.5%

— AMARIN CORP PLC -ADR 11.3%

Value ($000) $19,647 Shares 946,379 Est. Cost $3.01 Unrealized —

LGND LIGAND PHARMACEUTICALS 10.8%

Value ($000) $18,857 Shares 150,000 Est. Cost $75.76 Unrealized 0.0%

— NEOS THERAPEUTICS INC 6.8%

Value ($000) $11,775 Shares 4,511,504 Est. Cost $1.88 Unrealized —

— APOLLO ENDOSURGERY INC 5.6%

Value ($000) $9,651 Shares 2,580,518 Est. Cost $4.60 Unrealized —

— BIODELIVERY SCIENCES INTL 4.7%

Value ($000) $8,159 Shares 1,539,437 Est. Cost $2.54 Unrealized —

— HTG MOLECULAR DIAGNOSTICS 4.1%

Value ($000) $7,089 Shares 2,835,786 Est. Cost $2.67 Unrealized —

— ADAMAS PHARMACEUTICALS INC 4.0%

Value ($000) $6,999 Shares 984,329 Est. Cost $7.11 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 4.0%

Value ($000) $6,983 Shares 1,201,975 Est. Cost $5.84 Unrealized -0.6%

— ALIMERA SCIENCES INC 4.0%

Value ($000) $6,873 Shares 6,483,610 Est. Cost $1.18 Unrealized —

— AEGERION PHARMACEUTICALSAEGR 2 08/15/19 3.5%

Value ($000) $6,032 Shares 9,000,000 Est. Cost $0.67 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 3.3%

Value ($000) $5,811 Shares 60,840 Est. Cost $89.70 Unrealized 0.0%

— OPHTHOTECH CORP 3.3%

Value ($000) $5,746 Shares 4,074,944 Est. Cost $2.69 Unrealized —

— CTI BIOPHARMA CORP 2.2%

Value ($000) $3,881 Shares 4,000,000 Est. Cost $3.06 Unrealized —

— OPIANT PHARMACEUTICALS INC 2.2%

Value ($000) $3,869 Shares 294,894 Est. Cost $16.22 Unrealized —

— APTEVO THERAPEUTICS INC 2.0%

Value ($000) $3,505 Shares 3,894,219 Est. Cost $0.90 Unrealized —

— VIVEVE MEDICAL INC 1.8%

Value ($000) $3,199 Shares 3,403,402 Est. Cost $6.92 Unrealized —

XOMA XOMA CORP 1.6%

Value ($000) $2,816 Shares 227,430 Est. Cost $13.68 Unrealized 0.0%

— FOAMIX PHARMACEUTICALS LTD 1.6%

Value ($000) $2,738 Shares 730,004 Est. Cost $4.50 Unrealized —

EBS EMERGENT BIOSOLUTIONS INC 1.4%

Value ($000) $2,364 Shares 46,800 Est. Cost $58.99 Unrealized 0.0%

— OXFORD IMMUNOTEC GLOBAL PLC 1.3%

Value ($000) $2,192 Shares 127,224 Est. Cost $16.23 Unrealized —

— MATINAS BIOPHARMA HOLDINGS I 1.3%

Value ($000) $2,189 Shares 2,008,006 Est. Cost $1.09 Unrealized —

— AFFIMED NV 1.2%

Value ($000) $2,124 Shares 505,736 Est. Cost $3.11 Unrealized —

— CHIASMA INC 0.9%

Value ($000) $1,560 Shares 300,000 Est. Cost $5.20 Unrealized —

— VERASTEM INC 0.9%

Value ($000) $1,480 Shares 500,000 Est. Cost $2.96 Unrealized —

— INTERPACE DIAGNOSTICS GROUP 0.7%

Value ($000) $1,147 Shares 1,434,030 Est. Cost $0.80 Unrealized —

DMAC DIAMEDICA THERAPEUTICS INC 0.7%

Value ($000) $1,135 Shares 250,000 Est. Cost $3.61 Unrealized 0.0%

XENE XENON PHARMACEUTICALS INC 0.6%

Value ($000) $1,004 Shares 98,860 Est. Cost $8.48 Unrealized 0.0%

— STRONGBRIDGE BIOPHARMA PLC 0.5%

Value ($000) $932 Shares 187,074 Est. Cost $4.98 Unrealized —

COLL COLLEGIUM PHARMACEUTICAL INC 0.5%

Value ($000) $909 Shares 60,045 Est. Cost $16.02 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VNDA	VANDA PHARMACEUTICALS INC	1,260,288	$23,189	13.3%	$21.40	+6.5%	COM	921659108
—	AMARIN CORP PLC -ADR	946,379	$19,647	11.3%	$3.01	—	SPONS ADR NEW	023111206
LGND	LIGAND PHARMACEUTICALS	150,000	$18,857	10.8%	$75.76	0.0%	COM NEW	53220K504
—	NEOS THERAPEUTICS INC	4,511,504	$11,775	6.8%	$1.88	—	COM	64052L106
—	APOLLO ENDOSURGERY INC	2,580,518	$9,651	5.6%	$4.60	—	COM	03767D108
—	BIODELIVERY SCIENCES INTL	1,539,437	$8,159	4.7%	$2.54	—	COM	09060J106
—	HTG MOLECULAR DIAGNOSTICS	2,835,786	$7,089	4.1%	$2.67	—	COM	40434H104
—	ADAMAS PHARMACEUTICALS INC	984,329	$6,999	4.0%	$7.11	—	COM	00548A106
CPIX	CUMBERLAND PHARMACEUTICALS	1,201,975	$6,983	4.0%	$5.84	-0.6%	COM	230770109
—	ALIMERA SCIENCES INC	6,483,610	$6,873	4.0%	$1.18	—	COM	016259103
—	AEGERION PHARMACEUTICALSAEGR 2 08/15/19	9,000,000	$6,032	3.5%	$0.67	—	NOTE 2.000% 8/1	00767EAB8
ENTA	ENANTA PHARMACEUTICALS INC	60,840	$5,811	3.3%	$89.70	0.0%	COM	29251M106
—	OPHTHOTECH CORP	4,074,944	$5,746	3.3%	$2.69	—	COM	683745103
—	CTI BIOPHARMA CORP	4,000,000	$3,881	2.2%	$3.06	—	COM NEW	12648L601
—	OPIANT PHARMACEUTICALS INC	294,894	$3,869	2.2%	$16.22	—	COM	683750103
—	APTEVO THERAPEUTICS INC	3,894,219	$3,505	2.0%	$0.90	—	COM	03835L108
—	VIVEVE MEDICAL INC	3,403,402	$3,199	1.8%	$6.92	—	COM NEW	92852W204
XOMA	XOMA CORP	227,430	$2,816	1.6%	$13.68	0.0%	COM NEW	98419J206
—	FOAMIX PHARMACEUTICALS LTD	730,004	$2,738	1.6%	$4.50	—	SHS	M46135105
EBS	EMERGENT BIOSOLUTIONS INC	46,800	$2,364	1.4%	$58.99	0.0%	COM	29089Q105
—	OXFORD IMMUNOTEC GLOBAL PLC	127,224	$2,192	1.3%	$16.23	—	ORD SHS	G6855A103
—	MATINAS BIOPHARMA HOLDINGS I	2,008,006	$2,189	1.3%	$1.09	—	COM	576810105
—	AFFIMED NV	505,736	$2,124	1.2%	$3.11	—	COM	N01045108
—	CHIASMA INC	300,000	$1,560	0.9%	$5.20	—	COM	16706W102
—	VERASTEM INC	500,000	$1,480	0.9%	$2.96	—	COM	92337C104
—	INTERPACE DIAGNOSTICS GROUP	1,434,030	$1,147	0.7%	$0.80	—	COM NEW	46062X204
DMAC	DIAMEDICA THERAPEUTICS INC	250,000	$1,135	0.7%	$3.61	0.0%	COM NEW	25253X207
XENE	XENON PHARMACEUTICALS INC	98,860	$1,004	0.6%	$8.48	0.0%	COM	98420N105
—	STRONGBRIDGE BIOPHARMA PLC	187,074	$932	0.5%	$4.98	—	SHS USD	G85347105
COLL	COLLEGIUM PHARMACEUTICAL INC	60,045	$909	0.5%	$16.02	0.0%	COM	19459J104